Wireframe preview

Best viewed on desktop.

This is a wireframe for review, not the finished site. The responsive (mobile) treatment comes in the design and build phase. Open this page on a screen at least 1200 px wide to see the layout as intended.

← The GRA Portfolio

MetasTx

Cancer treatment

MetasTx is developing a novel drug to treat prostate cancer. Its formulation, MTX-101, has been shown to suppress the growth of tumor cells and inhibit metastasis into other parts of the body. Importantly, mice-based clinical trials demonstrated no detectable toxicity, unlike many existing cancer treatments.

First developed at UGA, MTX-101 has been shown in tests that it does not deplete testosterone, a critical advancement in this medicine.

The next phase of the company’s research will involve in vivo tests on human, with the aim of producing a safe and effective drug on a commercial scale.